SCHEMBL10144244

SCHEMBL10144244

Bc1ccc2oc(-c3ccc(N(C)C)cc3)cc(=O)c2c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.71
TNKS O95271 1/20 0.68
QPCT Q16769 1/20 0.60
CRHBP P24387 1/20 0.58
CRHR2 Q13324 1/20 0.58
TNNI3 P19429 1/20 0.58
TNNT2 P45379 1/20 0.58
TNNC1 P63316 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.54
AR P10275 1/20 0.53
PLA2G2A P14555 1/20 0.52
PLA2G4A P47712 1/20 0.52
TP53 P04637 3/20 0.51
CYP3A4 P08684 3/20 0.51
MAPT P10636 3/20 0.51
HPGD P15428 3/20 0.51
NPC1 O15118 2/20 0.51
LMNA P02545 2/20 0.51
THRB P10828 2/20 0.51
RAB9A P51151 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4985743 0.83 APP (1.00) APPTNKSQPCTCRHBPCRHR2
SCHEMBL4990064 0.83 APP (0.71) APPTNKSQPCTCRHBPCRHR2
SCHEMBL4985815 0.83 QPCT (0.80) APPTNKSQPCTCRHBPCRHR2
SCHEMBL2423832 0.81 TNKS (1.00) APPTNKSQPCTL3MBTL1AR
SCHEMBL10144254 0.81 MAPT (0.77) APPTNKSQPCTPLA2G2APLA2G4A
SCHEMBL4985779 0.81 MAPT (0.80) APPTNKSTP53CYP3A4MAPT
SCHEMBL14697041 0.80 TNKS (0.68) APPTNKSQPCTCRHBPCRHR2
SCHEMBL22032720 0.80 QPCT (0.79) APPTNKSQPCTARCYP3A4
SCHEMBL14433139 0.77 GABRP (0.72) TNKSARPLA2G2APLA2G4ATP53
SCHEMBL15199281 0.76 SIGMAR1 (0.64) APPTNKS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8192717-B2 Flavone derivative, chalcone derivative, styrylchromone derivative, or a coumarin derivative with high binding specificity to an amyloid beta protein, high permeability to a blood-brain barrier, and ability to rapidly disappear from sites other than cerebral senile plaque; also drug screening NAGASAKI UNIVERSITY (JP) 2012-06-05 US disclosed
US-20080131367-A1 Composition For Diagnosing Amyloid-Related Diseases Mori, Hiroshi (JP) 2008-06-05 US disclosed
EP-1815872-A1 COMPOSITION FOR AMYLOID-ASSOCIATED DISEASE DIAGNOSIS Nagasaki University (JP) 2007-08-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080131367-A1 Composition For Diagnosing Amyloid-Related Diseases APP, APBA1, FABP7 APP 1/4885TNKS 4609/4885QPCT 1735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.